Mice treated with a benzodiazepine had an improved survival rate following Pseudomonas aeruginosa infection.
Psychological stress has a high incidence after burn injury, therefore, anxiolytic drugs are often prescribed. Unfortunately, to date, no burn study has investigated the effects of anxiolytic drugs on the ability to fight infection. This study was undertaken to determine if psychological stress, anxiety-modulating drugs, or both, alter survival following an infection. On day 0, 7-week-old male C57Bl/6 mice either received a 15% full-thickness flame burn or were sham treated (anesthesia and shaved), whereas controls received no treatment. Mice received midazolam (1 mg/kg intraperitoneally) or saline daily and were stressed by exposure to rat in a guinea pig cage or placed in an empty cage for 1 hour a day, beginning on postburn day 1. For the survival experiments, mice either received bacteria after 2 or 8 consecutive days of predator exposure and drug treatment, which continued daily for 7 days after inoculation. In a separate set of experiments, after eight daily injections of midazolam, mice were given lipopolysaccharide, bacteria, or saline and were killed 12 hours later. Mice that received midazolam had improved survival rates when compared with their saline-treated counterparts, and the protective effect was more significant the more days they received the drug. For most of the cytokines, the bacteria-induced increase was significantly attenuated by midazolam as was the amount of bacteria in the liver. The protective effect seems to be independent of the drug's anxiolytic activity as there were no significant differences in survival between the predator-stressed and the nonstressed mice. The mechanisms responsible for the protective effect remain to be elucidated.
Dugan
Amy L
AL
Department of Research, Shriners Hospital Cincinnati, Ohio, USA.
Gregerson
Karen A
KA
Neely
Alice
A
Gardner
Jason
J
Noel
Greg J
GJ
Babcock
George F
GF
Horseman
Nelson D
ND
D000818:Animals; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D002056:Burns / Q000382:microbiology / Q000523:psychology* / Q000628:therapy; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008874:Midazolam / Q000627:therapeutic use*; D011552:Pseudomonas Infections / Q000209:etiology / Q000523:psychology / Q000628:therapy*; D011550:Pseudomonas aeruginosa; D051381:Rats; D020318:Rats, Long-Evans; D013315:Stress, Psychological / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology
D014151:Anti-Anxiety Agents; D008874:Midazolam